121 related articles for article (PubMed ID: 21856740)
1. Strong activation of ether-à-go-go-related gene 1 K+ channel isoforms by NS1643 in human embryonic kidney 293 and Chinese hamster ovary cells.
Schuster AM; Glassmeier G; Bauer CK
Mol Pharmacol; 2011 Nov; 80(5):930-42. PubMed ID: 21856740
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of action of a novel human ether-a-go-go-related gene channel activator.
Casis O; Olesen SP; Sanguinetti MC
Mol Pharmacol; 2006 Feb; 69(2):658-65. PubMed ID: 16284303
[TBL] [Abstract][Full Text] [Related]
3. Activation of human ether-a-go-go-related gene potassium channels by the diphenylurea 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643).
Hansen RS; Diness TG; Christ T; Demnitz J; Ravens U; Olesen SP; Grunnet M
Mol Pharmacol; 2006 Jan; 69(1):266-77. PubMed ID: 16219910
[TBL] [Abstract][Full Text] [Related]
4. Effects of the small molecule HERG activator NS1643 on Kv11.3 channels.
Bilet A; Bauer CK
PLoS One; 2012; 7(11):e50886. PubMed ID: 23226420
[TBL] [Abstract][Full Text] [Related]
5. The human ether-a-go-go-related gene activator NS1643 enhances epilepsy-associated KCNQ channels.
Li P; Chen X; Zhang Q; Zheng Y; Jiang H; Yang H; Gao Z
J Pharmacol Exp Ther; 2014 Dec; 351(3):596-604. PubMed ID: 25232191
[TBL] [Abstract][Full Text] [Related]
6. Activation of ERG2 potassium channels by the diphenylurea NS1643.
Elmedyb P; Olesen SP; Grunnet M
Neuropharmacology; 2007 Aug; 53(2):283-94. PubMed ID: 17610913
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of Kv11.1 activators on Kv11.1a, Kv11.1b and Kv11.1a/Kv11.1b channels.
Larsen AP; Bentzen BH; Grunnet M
Br J Pharmacol; 2010 Oct; 161(3):614-28. PubMed ID: 20880400
[TBL] [Abstract][Full Text] [Related]
8. Potent activation of large-conductance Ca2+-activated K+ channels by the diphenylurea 1,3-bis-[2-hydroxy-5-(trifluoromethyl)phenyl]urea (NS1643) in pituitary tumor (GH3) cells.
Wu SN; Peng H; Chen BS; Wang YJ; Wu PY; Lin MW
Mol Pharmacol; 2008 Dec; 74(6):1696-704. PubMed ID: 18809671
[TBL] [Abstract][Full Text] [Related]
9. Structure-guided topographic mapping and mutagenesis to elucidate binding sites for the human ether-a-go-go-related gene 1 potassium channel (KCNH2) activator NS1643.
Durdagi S; Guo J; Lees-Miller JP; Noskov SY; Duff HJ
J Pharmacol Exp Ther; 2012 Aug; 342(2):441-52. PubMed ID: 22573844
[TBL] [Abstract][Full Text] [Related]
10. NS1643 enhances ionic currents in a G604S-WT hERG co-expression system associated with long QT syndrome 2.
Huo J; Guo X; Lu Q; Qiang H; Liu P; Bai L; Huang CL; Zhang Y; Ma A
Clin Exp Pharmacol Physiol; 2017 Nov; 44(11):1125-1133. PubMed ID: 28741726
[TBL] [Abstract][Full Text] [Related]
11. Effects of TRH on heteromeric rat erg1a/1b K+ channels are dominated by the rerg1b subunit.
Kirchberger NM; Wulfsen I; Schwarz JR; Bauer CK
J Physiol; 2006 Feb; 571(Pt 1):27-42. PubMed ID: 16339175
[TBL] [Abstract][Full Text] [Related]
12. Molecular determinants of human ether-à-go-go-related gene 1 (hERG1) K+ channel activation by NS1643.
Grunnet M; Abbruzzese J; Sachse FB; Sanguinetti MC
Mol Pharmacol; 2011 Jan; 79(1):1-9. PubMed ID: 20876384
[TBL] [Abstract][Full Text] [Related]
13. Probing the binding sites and mechanisms of action of two human ether-a-go-go-related gene channel activators, 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643) and 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD307243).
Xu X; Recanatini M; Roberti M; Tseng GN
Mol Pharmacol; 2008 Jun; 73(6):1709-21. PubMed ID: 18372399
[TBL] [Abstract][Full Text] [Related]
14. NS1643 interacts around L529 of hERG to alter voltage sensor movement on the path to activation.
Guo J; Cheng YM; Lees-Miller JP; Perissinotti LL; Claydon TW; Hull CM; Thouta S; Roach DE; Durdagi S; Noskov SY; Duff HJ
Biophys J; 2015 Mar; 108(6):1400-1413. PubMed ID: 25809253
[TBL] [Abstract][Full Text] [Related]
15. Investigating the utility of adult zebrafish ex vivo whole hearts to pharmacologically screen hERG channel activator compounds.
Hull CM; Genge CE; Hobbs Y; Rayani K; Lin E; Gunawan M; Shafaattalab S; Tibbits GF; Claydon TW
Am J Physiol Regul Integr Comp Physiol; 2019 Dec; 317(6):R921-R931. PubMed ID: 31664867
[TBL] [Abstract][Full Text] [Related]
16. Erg K+ channels modulate contractile activity in the bovine epididymal duct.
Mewe M; Wulfsen I; Schuster AM; Middendorff R; Glassmeier G; Schwarz JR; Bauer CK
Am J Physiol Regul Integr Comp Physiol; 2008 Mar; 294(3):R895-904. PubMed ID: 18184764
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of hERG1 channel isoforms reproduces properties of native I(Kr) and modulates cardiac action potential characteristics.
Larsen AP; Olesen SP
PLoS One; 2010 Feb; 5(2):e9021. PubMed ID: 20126398
[TBL] [Abstract][Full Text] [Related]
18. Computational analysis of the effects of the hERG channel opener NS1643 in a human ventricular cell model.
Peitersen T; Grunnet M; Benson AP; Holden AV; Holstein-Rathlou NH; Olesen SP
Heart Rhythm; 2008 May; 5(5):734-41. PubMed ID: 18452879
[TBL] [Abstract][Full Text] [Related]
19. Kinetic model for NS1643 drug activation of WT and L529I variants of Kv11.1 (hERG1) potassium channel.
Perissinotti LL; Guo J; De Biase PM; Clancy CE; Duff HJ; Noskov SY
Biophys J; 2015 Mar; 108(6):1414-1424. PubMed ID: 25809254
[TBL] [Abstract][Full Text] [Related]
20. 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD-307243) causes instantaneous current through human ether-a-go-go-related gene potassium channels.
Gordon E; Lozinskaya IM; Lin Z; Semus SF; Blaney FE; Willette RN; Xu X
Mol Pharmacol; 2008 Mar; 73(3):639-51. PubMed ID: 18042732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
